11.48
-0.26
(-2.21%)
At close: January 29 at 4:00:02 PM EST
11.48
0.00
(0.00%)
After hours: January 29 at 4:08:12 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
2,477.00
25,892.00
10,677.00
20,755.87
Investing Cash Flow
-16,541.00
-19,760.00
-13,814.00
-8,190.80
Financing Cash Flow
3,638.00
2,500.00
--
-6,825.28
End Cash Position
15,653.00
33,509.00
25,175.00
26,089.02
Capital Expenditure
-4,708.00
-8,586.00
-4,998.00
-8,452.49
Issuance of Capital Stock
--
2,500.00
--
--
Repayment of Debt
--
--
-466.28
-6,702.91
Free Cash Flow
-2,231.00
17,306.00
5,679.00
12,303.38
12/31/2021 - 4/12/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SRZN Surrozen, Inc.
11.25
+4.46%
1GDA.F Zevra Therapeutics, Inc.
7.45
-5.10%
F6T.MU Fate Therapeutics Inc
1.2810
0.00%
1BT.F Enlivex Therapeutics Ltd.
1.0700
-0.93%
471A.F aTyr Pharma, Inc.
3.2800
0.00%
GYX.F Futura Medical plc
0.3440
+1.18%
HQ1.MU Oruka Therapeutics Inc. R
11.20
0.00%
CVAC.VI CureVac N.V.
3.7820
+0.69%
4SG.F Sol-Gel Technologies Ltd.
0.6450
-7.86%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.4700
+0.64%